Authors
Jonathan D Rohrer, Adrian M Isaacs, Sarah Mizielinska, Simon Mead, Tammaryn Lashley, Selina Wray, Katie Sidle, Pietro Fratta, Richard W Orrell, John Hardy, Janice Holton, Tamas Revesz, Martin N Rossor, Jason D Warren
Publication date
2015/3/1
Source
The Lancet Neurology
Volume
14
Issue
3
Pages
291-301
Publisher
Elsevier
Description
C9orf72 hexanucleotide repeat expansions are the most common cause of familial frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS) worldwide. The clinical presentation is often indistinguishable from classic FTD or ALS, although neuropsychiatric symptoms are more prevalent and, for ALS, behavioural and cognitive symptoms occur more frequently. Pathogenic repeat length is in the hundreds or thousands, but the minimum length that increases risk of disease, and how or whether the repeat size affects phenotype, are unclear. Like in many patients with FTD and ALS, neuronal inclusions that contain TARDBP are seen, but are not universal, and the characteristic pathological finding is of dipeptide repeat (DPR) proteins, formed by unconventional repeat-associated non-ATG translation. Possible mechanisms of neurodegeneration include loss of C9orf72 protein and function, RNA toxicity, and …
Total citations
201520162017201820192020202120222023202423474838223321221710
Scholar articles